Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03014804
Title Dendritic Cell-Autologous Lung Tumor Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jonsson Comprehensive Cancer Center
Indications

glioblastoma

Therapies

DCVax-L

DCVax-L + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCLA / Jonsson Comprehensive Cancer Center Los Angeles California 90095 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field